MedTrace Logo

Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma

NCT03430635 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-02-13

No results posted yet for this study

Summary

¹¹C-choline positron emission tomography/computed tomography (PET/CT) has been used in patients with some types of solid cancers, but few data are available in patients undergoing hepatectomy for hepatocellular carcinoma (HCC). The aim of this study was to analyze the prognostic value of metabolic imaging data by using ¹¹C-choline PET/CT in patients with HCC before hepatectomy.

Conditions

Interventions

PROCEDURE

Hepatectomy

Surgery of the liver: removal of a given part of the liver affected by hepatocellular carcinoma

Sponsors & Collaborators

  • Humanitas Clinical and Research Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2015-12-31
Completion
2016-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03430635 on ClinicalTrials.gov